Discontinued — last reported Q4 '25
Oncology Assay Interpretation Services — Revenue Remaining Performance Obligation
Natera, Inc. Oncology Assay Interpretation Services — Revenue Remaining Performance Obligation remained flat by 0.0% to $20.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $20.00M to $20.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests a growing backlog of contracted work and stronger future revenue visibility, while a decrease may indicate faster fulfillment or slowing demand for future services.
Detailed definition
This metric represents the total transaction price allocated to performance obligations that are unsatisfied or partiall...
Peer comparison
Commonly reported by diagnostic and life sciences companies as 'Backlog' or 'Remaining Performance Obligations' under ASC 606.
ntra_segment_oncology_assay_interpretation_services_revenue_remaining_performance_obligationHistorical Data
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $5.00M | $5.00M | $20.00M | $20.00M | $5.00M | $5.00M | $20.00M | $20.00M |
| QoQ Change | — | +0.0% | +300.0% | +0.0% | -75.0% | +0.0% | +300.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | -75.0% | +0.0% | +0.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Natera, Inc.'s oncology assay interpretation services — revenue remaining performance obligation?
- Natera, Inc. (NTRA) reported oncology assay interpretation services — revenue remaining performance obligation of $20.00M in Q4 2025.
- How has Natera, Inc.'s oncology assay interpretation services — revenue remaining performance obligation changed year-over-year?
- Natera, Inc.'s oncology assay interpretation services — revenue remaining performance obligation decreased by 0.0% year-over-year, from $20.00M to $20.00M.
- What does oncology assay interpretation services — revenue remaining performance obligation mean?
- The total value of contracted oncology diagnostic services that the company has yet to perform or deliver.